We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

74 hedge funds and large institutions have $135M invested in Gyre Therapeutics in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

18% more capital invested

Capital invested by funds: $114M → $135M (+$20.4M)

4% more funds holding

Funds holding: 71 → 74 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

66% less call options, than puts

Call options by funds: $1.73M | Put options by funds: $5.08M

Holders
74
Holders Change
+3
Holders Change %
+4.23%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
27
Reduced
22
Closed
5
Calls
$1.73M
Puts
$5.08M
Net Calls
-$3.35M
Net Calls Change
+$2.12M

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$10.6M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$1.08M
3
HVC
Healthcare Value Capital
New Jersey
+$1.03M
4
JGC
J. Goldman & Co
New York
+$893K
5
Franklin Resources
Franklin Resources
California
+$777K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$21.7M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$599K
3
RFC
Russell Frank Company
Washington
-$523K
4
CCMH
Cornerstone Capital Management Holdings
New York
-$422K
5
Barclays
Barclays
United Kingdom
-$382K
Name Holding Trade Value Shares
Change 		Change in
Stake
TC
26
TFS Capital
Pennsylvania
$643K +$620K +154 New
BCM
27
Bridgeway Capital Management
Texas
$575K +$8.05K +2 +1%
B
28
Bailard
California
$566K – – –
BIM
29
BlackRock Investment Management
Delaware
$521K – – –
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$442K +$52.3K +13 +14%
TI
31
Turner Investments
Pennsylvania
$430K +$414K +103 New
Jacobs Levy Equity Management
32
Jacobs Levy Equity Management
New Jersey
$376K -$342K -85 -49%
NI
33
Numeric Investors
Massachusetts
$346K +$141K +35 +73%
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$268K +$8.05K +2 +3%
CCMH
35
Cornerstone Capital Management Holdings
New York
$266K -$422K -105 -63%
AA
36
Ancora Advisors
Ohio
$266K -$44.3K -11 -15%
PPA
37
Parametric Portfolio Associates
Washington
$262K -$48.3K -12 -16%
Morgan Stanley
38
Morgan Stanley
New York
$242K -$362K -90 -61%
RFC
39
Russell Frank Company
Washington
$223K -$523K -130 -71%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$220K -$4.02K -1 -2%
PAM
41
Panagora Asset Management
Massachusetts
$216K +$56.3K +14 +37%
TA
42
Teachers Advisors
New York
$214K -$4.02K -1 -2%
RA
43
Royce & Associates
New York
$212K – – –
Charles Schwab
44
Charles Schwab
California
$206K – – –
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$188K – – –
AllianceBernstein
46
AllianceBernstein
Tennessee
$184K -$12.1K -3 -6%
VRS
47
Virginia Retirement Systems
Virginia
$181K – – –
SIM
48
Spark Investment Management
New York
$175K +$84.5K +21 +100%
NFA
49
Nationwide Fund Advisors
Ohio
$168K +$4.02K +1 +3%
ARTA
50
A.R.T. Advisors
New York
$162K +$157K +39 New
1
2
3 4

GYRE Hedge Fund Activity: Q3 2013 in Review

74 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q3 2013, worth a combined $135M — up 18% from $114M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new GYRE positions and 5 closed out — a net gain of 5 holders — while 27 added to existing stakes and 22 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $10.6M. The largest seller was Fidelity Investments, cutting an estimated $21.7M.

  • 74 institutional investors held Gyre Therapeutics (GYRE) as of Q3 2013, up from 71 in Q2 2013.
  • Funds reported $135M of Gyre Therapeutics stock for Q3 2013, up 18% quarter-over-quarter.
  • 10 funds opened new Gyre Therapeutics positions in Q3 2013 and 5 closed out, a net change of +5 holders.
  • The largest Gyre Therapeutics buyer in Q3 2013 was Baker Bros. Advisors, an estimated $10.6M added.
  • The largest Gyre Therapeutics seller in Q3 2013 was Fidelity Investments, an estimated $21.7M sold.

Based on aggregated 13F filings for Q3 2013.